ClinicalTrials.govpublic full text
Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
anemia, liver disease, hypoxemia, hht, iron deficiency anemia, liver disease with high cardiac output, diffuse pulmonary avms with hypoxemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848167
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.